Table 2 Baseline characteristics of subjects categorised by statin use at study enrolment
| Characteristics | Statin use (n = 976) | No statin use (n = 1697) | p Value |
| Age (years), mean (SD) | 66.8 (6.2) | 66.5 (6.9) | 0.14 |
| Race | 0.01 | ||
| White | 883 (90) | 1484 (87) | |
| Black | 57 (6) | 155 (9) | |
| Hispanic | 18 (2) | 36 (2) | |
| Other | 18 (2) | 22 (1) | |
| Prior myocardial infarction or revascularisation | 470 (48) | 891 (53) | 0.03 |
| History of heart failure | 104 (11) | 229 (13) | 0.03 |
| Diabetes | 211 (22) | 399 (24) | 0.27 |
| Hypertension | 570 (59) | 1003 (60) | 0.71 |
| Left ventricular hypertrophy by ECG | 89 (9) | 180 (11) | 0.25 |
| Exercise > 3 times per week | 403 (41) | 637 (38) | 0.06 |
| Any alcohol use | 415 (43) | 639 (38) | 0.01 |
| Body mass index (kg/m2), mean (SD) | 28.5 (5.3) | 28.7 (5.6) | 0.59 |
| ACE inhibitor use | 180 (18) | 288 (17) | 0.34 |
| Antiarrhythmic drug use | 10 (1) | 29 (2) | 0.16 |
-
Results are presented as number (%) unless stated otherwise.
